华润医药想补上“创新”短板

新浪财经
18 Feb

医药行业 严冬下,仅有约三成的药企实现了利润正增长。目前,已有多家上市公司相继披露了2024年业绩预告。其中,A股500家上市药企里,约300家进行了预报。在这近300家药企中,实现净利润正增长的约有四成。然而,在剔除掉那些亏损减少的企业后,净利润为正且实现正增长的药企数量,占比降至约三成。从以上不难看出,大多数药企目前仍深陷泥沼,医药行业距离全面复苏尚有一段距离。不过,华润系旗下的多家药企却实现...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10